The ApiJect Platform brings together prefilled, single-dose parenterals with scalable, efficient manufacturing to solve drug delivery challenges for liquid drugs in all markets.
The ApiJect Platform creates prefilled parenteral devices by bringing together Blow-Fill-Seal advanced aseptic drug packaging with attachable drug delivery components. This allows us to design a cost-effective, prefilled drug delivery system that is tailored to a partner’s specific drug product.
We do this by customizing the right Blow-Fill-Seal drug container to aseptically fill-finish the drug product. Then we design it so simple plastic delivery systems, such as needle hubs, can be attached to the prefilled BFS container, easily and securely. This enables the drug product to be directly delivered to the patient.
Once design is approved, the ApiJect Platform allows our team to rapidly design the necessary molds and build a prototype device for performance testing. This is largely done at the ApiJect Technology Development Center in the greater Orlando, Florida area.
When the pharma or biotech partner is ready for development and manufacturing runs, we license our molds, components, and expertise to help them successfully and cost-effectively fill-finish their drug products in our prefilled injection delivery systems.
The end result, once approved by regulators, is a drug delivery system, manufactured as individual components, that the healthcare worker can connect together in seconds just prior to administration to the patient.